Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

MS Drug May Be Effective in Treating Brain Cancer

Published research shows promise in using Sanofi’s multiple sclerosis drug Aubagio in addition to targeted cancer therapy to treat the aggressive brain cancer glioblastoma.

Read More »

Superbugs found lurking in London underground and hospitals

Scientists have found multidrug-resistant “superbug” bacteria lurking on cash machines, escalators and handrails in London’s underground rail system, shopping centers and hospitals and say they pose a potential risk to public health.

Read More »

Two Experimental Drugs Show Promise in Inhibiting Ebola Virus

The U.S. Centers for Disease Control and Prevention (CDC) published research in the journal Lancet Infectious Diseases outlining the results from two experimental Ebola drugs, Gilead Sciences’ remdesivir and Mapp Biopharmaceutical’s ZMapp.

Read More »

Few supplements have proven heart benefits

Few nutritional supplements can protect people from developing or dying from cardiovascular disease, and some may actually be harmful, a research review suggests.

Read More »

The Importance of Increasing Diversity in Genetic Research

The advent of increasingly more mainstream and affordable genetic testing enables powerful genetic research – but that power is directly associated with the strength and diversity of the database of genetic information available.

Read More »

ADA Spotlight: Novo Nordisk, Boehringer Ingelheim, Eli Lilly and More

Almost 15,000 physicians, scientists, health-care professionals and industry representatives from around the globe presented research, treatment recommendations and advances toward a diabetes cure at the American Diabetes Association (ADA)’s 79th Scientific Sessions in San Francisco.

Read More »

Without heart disease, daily aspirin may be too risky

For people without heart disease, taking a daily aspirin to prevent heart attacks and strokes may increase the risk of severe brain bleeding to the point where it outweighs any potential benefit, a research review suggests.

Read More »

Infuse storytelling with imagination and light up the brain

Our brains are hard-wired to receive information primarily through storytelling. The more imaginative, the better. Imagination is a powerful tool.

Read More »

OncoSec and Duke Announce New Collaboration in Cancer Research

OncoSec Medical Incorporated and Duke University School of Medicine announced that they have entered into a collaborative research agreement to evaluate the use of OncoSec’s proprietary Tavoplus (enhanced IL-12 DNA-plasmid) in combination or sequence with a HER2-plasmid vaccine administered with OncoSec’s novel intratumoral delivery system.

Read More »

NASA’s Landmark Twins Study Reveals Resilience of Human Body in Space

Results from NASA’s landmark Twins Study reveals some interesting, surprising and reassuring data.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom